Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
YNK-105 by Yinuoke for Cancer Anorexia-Cachexia Syndrome: Likelihood of Approval
YNK-105 is under clinical development by Yinuoke and currently in Phase I for Cancer Anorexia-Cachexia Syndrome. According to GlobalData, Phase...